C07D 309/06
Radicals substituted by oxygen atoms
C07D309/06 (Radicals substituted by oxygen atoms) appears on 365 US grants and 351 published applications in this corpus.
Search patents in C07D- Granted patents
- 365
- Published applications
- 351
- Assignees
- 235
- Inventors
- 1,349
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 6 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 7 | 0 |
| 1990 | 5 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 9 | 0 |
| 1995 | 9 | 0 |
| 1996 | 13 | 0 |
| 1997 | 9 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 7 | 3 |
| 2003 | 5 | 9 |
| 2004 | 3 | 10 |
| 2005 | 3 | 13 |
| 2006 | 3 | 11 |
| 2007 | 9 | 11 |
| 2008 | 6 | 10 |
| 2009 | 6 | 12 |
| 2010 | 8 | 5 |
| 2011 | 6 | 11 |
| 2012 | 9 | 21 |
| 2013 | 15 | 18 |
| 2014 | 20 | 23 |
| 2015 | 16 | 28 |
| 2016 | 24 | 29 |
| 2017 | 18 | 22 |
| 2018 | 17 | 13 |
| 2019 | 12 | 11 |
| 2020 | 15 | 15 |
| 2021 | 10 | 12 |
| 2022 | 9 | 11 |
| 2023 | 6 | 19 |
| 2024 | 8 | 8 |
| 2025 | 3 | 17 |
| 2026 | 8 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Processes for preparing modulators of alpha-1 antitrypsin7 Jul 2026US 12,673,952 B2Vertex Pharmaceuticals Incorporated
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Dihydrooxazole and thiourea derivatives modulating the NLRP3 inflammasome pathway12 May 2026US 12,624,010 B2AC Immune SA
- 3-phenylpropylamine derivative21 Apr 2026US 12,606,533 B2Daiichi Sankyo Company, Limited
- Phenol derivative31 Mar 2026US 12,590,063 B2Sumitomo Pharma Co., Ltd.
- Novel compound, and pharmaceutical composition comprising same as active ingredient10 Sep 2026US 2026/0265189 A1Sapiensbio Inc.
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Lipid compounds, compositions, and uses thereof20 Aug 2026US 2026/0242346 A1Liberate Bio, Inc.
- Lipid compounds, compositions, and uses thereof13 Aug 2026US 2026/0234115 A1Liberate Bio, Inc.
- New compounds for treating streptococcus infections6 Aug 2026US 2026/0225998 A1AB2 Therapeutics, S. L.
Most cited
By later US patents
- Anticonvulsant sulfamate derivatives134US 4,513,006 AMcNeil Lab, Inc. · 1985
- Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity80US 5,489,584 AAllergan, Inc. · 1996
- Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity76US 5,543,534 AAllergan, Inc. · 1996
- Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity70US 5,514,825 AAllergan, Inc. · 1996
- Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity62US 5,648,503 AAllergan, Inc. · 1997